CPhI SEA Targets Fighting Low Quality Drugs in Indonesia

JAKARTA, Indonesia, March 2, 2016 /PRNewswire/ -- Indonesia continues - unabated - its growth as one of the fastest-expanding pharmaceutical markets in the Asia Pacific region.

At the same time, it is also still notable for its lax intellectual property laws, which have prompted heated criticism by international bodies in recent years. While the intent of these laws is to protect and grow domestic businesses, the WHO and PhRMA have expressed clear concerns about both the violation of international intellectual property standards and the potential dissemination of counterfeit, low-quality drugs. This is why it is extremely important to have a trading platform in Indonesia that is globally renowned to host the best producers and distributors in the pharma industry: CPhI SEA.

If you are looking for sustainable, quality ingredients, products, technology, solutions, register online and visit CPhI SEA, the only regional event dedicated to the pharma industry, held at Jakarta International Expo during April 6-8, 2016.

The CPhI series of events drives growth and innovation in the global pharmaceutical industry, with leading exhibitions and online communities covering every step of the supply chain from drug discovery to finished dosage.

More than 100,000 visitors meet over 6,000 exhibitors at events in Europe, China, India, Japan, South East Asia, Russia, Brazil, Turkey and Korea every year to exchange ideas, form alliances and conduct business on an international scale. CPhI also provides an online buyer & supplier directory at CPhI-Online.com.

Contact:

Ivan Ferrari
+62 21 2930 5959 ext 138
[email protected]

Logo - http://photos.prnewswire.com/prnh/20121014/HK92339LOGO-d

SOURCE CPhI - UBM